Search

Your search keyword '"Atsuyuki Tomizawa"' showing total 24 results

Search Constraints

Start Over You searched for: Author "Atsuyuki Tomizawa" Remove constraint Author: "Atsuyuki Tomizawa"
24 results on '"Atsuyuki Tomizawa"'

Search Results

1. Prasugrel, a Platelet P2Y12 Receptor Antagonist, Improves Abnormal Gait in a Novel Murine Model of Thrombotic Hindlimb Ischemia

2. A Novel Model of Intravital Platelet Imaging Using CD41-ZsGreen1 Transgenic Rats.

3. The active metabolite of prasugrel, R-138727, improves cerebral blood flow and reduces cerebral infarction and neurologic deficits in a non-human primate model of acute ischaemic stroke

4. Vasodilator-stimulated phosphoprotein (VASP) is not a major mediator of platelet aggregation, thrombogenesis, haemostasis, and antiplatelet effect of prasugrel in rats

5. Prevention of occlusive arterial thrombus formation by a single loading dose of prasugrel suppresses neointimal hyperplasia in mice

6. Induction of Diabetes Abolishes the Antithrombotic Effect of Clopidogrel in Apolipoprotein E–Deficient Mice

7. Comparison of antiplatelet effects of prasugrel and ticagrelor in cynomolgus monkeys by an ELISA-based VASP phosphorylation assay and platelet aggregation

8. Abstract 321: Prasugrel, a Platelet P2y 12 Receptor Antagonist, Improves Abnormal Gait in a Novel Murine Model of Thrombotic Hind Limb Ischaemia

9. Nitroxide Derivatives for Imaging of Hypercholesterolemia-Induced Kidney Dysfunction and Assessing the Effectiveness of Antilipidemic Drugs

10. The Effect of Subchronic Administration of 7-(4-Fluorobenzyloxy)-2,3-dimethyl-1-{[(1S,2S)-2-methylcyclopropyl]methyl}-1H-pyrrolo[2,3-d]pyridazine (CS-526), a Novel Acid Pump Antagonist, on Gastric Acid Secretion and Gastrin Levels in Rats

11. Abstract WP278: Effects of Prasugrel on Cerebral Infarction and Neurological Deficits in a Non-human Primate Model of Thrombotic Stroke

12. A Novel Model of Intravital Platelet Imaging Using CD41-ZsGreen1 Transgenic Rats

13. Abstract 13183: A Novel Model of in vivo Platelet Thrombus Imaging Using CD41-ZsGreen1 Transgenic Rats

14. Prasugrel reduces ischaemic infarct volume and ameliorates neurological deficits in a non-human primate model of middle cerebral artery thrombosis

15. Platelet activation biomarkers in Berkeley sickle cell mice and the response to prasugrel

16. Selective blockade of P2Y12 receptors by prasugrel inhibits myocardial infarction induced by thrombotic coronary artery occlusion in rats

17. Carbamoyl-PROXYL-enhanced MRI detects very small disruptions in brain vascular permeability induced by dietary cholesterol

18. Pharmacodynamic and pharmacokinetic evaluation of CS-526 in cynomolgus monkeys

19. Pharmacological profile of novel acid pump antagonist 7-(4-fluorobenzyloxy)-2,3-dimethyl-1-{[(1S,2S)-2-methyl cyclopropyl]methyl}-1H-pyrrolo[2,3-d]pyridazine (CS-526)

20. Histological and functional analysis of vascular smooth muscle cells in a novel culture system with honeycomb-like structure

22. Characterization of platelet aggregation responses in microminipigs: Comparison with miniature pigs and the influence of dual antiplatelet administration of aspirin plus prasugrel.

24. Platelet activation biomarkers in Berkeley sickle cell mice and the response to prasugrel.

Catalog

Books, media, physical & digital resources